Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Microsoft
MSFT
|
+$725M |
| 3 |
Apple
AAPL
|
+$628M |
| 4 |
Amazon
AMZN
|
+$487M |
| 5 |
Meta Platforms (Facebook)
META
|
+$355M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$121M |
| 2 |
KE Holdings
BEKE
|
+$31.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$24.4M |
| 4 |
X
US Steel
X
|
+$18.4M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$15.6M |
Sector Composition
| 1 | Technology | 34.97% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Communication Services | 10.31% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAUC
1851
Allied Gold Corporation
AAUC
$1.79B
| $1.83M | ﹤0.01% |
+136,766
| New | +$1.83M |
|
1852
Fastly
FSLY
$1.14B
| $1.83M | ﹤0.01% |
259,000
| – | – |
|
1853
Janux Therapeutics
JANX
$1.45B
| $1.83M | ﹤0.01% |
79,100
| – | – |
|
1854
Sprinklr
CXM
$1.88B
| $1.82M | ﹤0.01% |
215,500
| – | – |
|
1855
Protolabs
PRLB
$1.18B
| $1.82M | ﹤0.01% |
45,400
-2,100
| -4% | -$84.1K |
|
1856
Collegium Pharmaceutical
COLL
$1.18B
| $1.82M | ﹤0.01% |
61,400
-1,100
| -2% | -$32.5K |
|
|
BRKL
1857
DELISTED
Brookline Bancorp
BRKL
| $1.81M | ﹤0.01% |
171,800
-2,900
| -2% | -$30.6K |
|
1858
Heidrick & Struggles
HSII
$1.03B
| $1.81M | ﹤0.01% |
39,600
| – | – |
|
1859
Thermon Group Holdings
THR
$844M
| $1.81M | ﹤0.01% |
64,300
-1,000
| -2% | -$28.1K |
|
1860
CVR Energy
CVI
$3.13B
| $1.8M | ﹤0.01% |
67,200
-1,000
| -1% | -$26.9K |
|
1861
Sally Beauty Holdings
SBH
$1.48B
| $1.8M | ﹤0.01% |
194,700
-3,800
| -2% | -$35.2K |
|
1862
Kohl's
KSS
$1.71B
| $1.8M | ﹤0.01% |
212,600
-3,000
| -1% | -$25.4K |
|
1863
Ardelyx
ARDX
$1.59B
| $1.8M | ﹤0.01% |
458,900
| – | – |
|
1864
NeoGenomics
NEO
$1.03B
| $1.8M | ﹤0.01% |
245,800
-2,900
| -1% | -$21.2K |
|
1865
LegalZoom.com
LZ
$1.9B
| $1.79M | ﹤0.01% |
200,900
| – | – |
|
1866
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $1.79M | ﹤0.01% |
64,600
-7,300
| -10% | -$202K |
|
1867
Scansource
SCSC
$974M
| $1.78M | ﹤0.01% |
42,600
-1,300
| -3% | -$54.4K |
|
|
SVM
1868
Silvercorp Metals
SVM
$1.15B
| $1.77M | ﹤0.01% |
418,300
-5,800
| -1% | -$24.5K |
|
|
SEI
1869
Solaris Energy Infrastructure, Inc.
SEI
$1.39B
| $1.77M | ﹤0.01% |
62,400
-3,900
| -6% | -$110K |
|
1870
Ecovyst
ECVT
$1.06B
| $1.76M | ﹤0.01% |
214,400
| – | – |
|
1871
Intellia Therapeutics
NTLA
$1.23B
| $1.76M | ﹤0.01% |
187,400
| – | – |
|
1872
Utz Brands
UTZ
$1.12B
| $1.75M | ﹤0.01% |
139,700
+3,700
| +3% | +$46.4K |
|
1873
Encore Capital Group
ECPG
$1.02B
| $1.75M | ﹤0.01% |
45,200
-700
| -2% | -$27.1K |
|
1874
Matsons
MATX
$3.29B
| $1.75M | ﹤0.01% |
15,700
-400
| -2% | -$44.5K |
|
1875
Yext
YEXT
$1.07B
| $1.75M | ﹤0.01% |
205,300
-4,800
| -2% | -$40.8K |
|